Skip to Main Content


Strategies and Considerations When Breaking Up Mass Actions After BMS

September 6, 2017 - DRI's The Voice
Social Logo Social Logo Social Logo

by Seth Wamelink and Madeline Dennis, published in DRI's The Voice

Numerous articles have detailed the Supreme Court’s groundbreaking decision in Bristol-Myers Squibb Co. v. Superior Ct., 137 S. Ct. 1773 (2017) (BMS). This article addresses the mechanics and practical considerations when deciding whether to use BMS to break up a mass action.

To read the article, click here.